LEP and chronic myelogenous leukemia, BCR-ABL1 positive: Thereafter, these effects are soon inhibited by leptin released by adipocytes that also increased the lipolysis of adipocytes [56] releasing SFA and MUFA that protect CML from apoptosis by activating the PI3K pathway.